Today: 21 May 2026
AI stock slips again as Anthropic’s ‘Cowork’ puts C3.ai back in focus
15 January 2026
1 min read

AI stock slips again as Anthropic’s ‘Cowork’ puts C3.ai back in focus

New York, January 15, 2026, 13:32 ET — Regular session

  • C3.ai shares slipped roughly 0.8% in afternoon trading, erasing part of Wednesday’s bounce.
  • William Blair’s analyst pointed out that Anthropic’s new “Cowork” tool dents sentiment around software stocks, but doesn’t affect the fundamentals.
  • Investors are gearing up for C3.ai’s upcoming earnings report, slated for late February.

C3.ai’s shares slipped roughly 0.8% on Thursday, erasing part of the previous day’s rally as investors reevaluated software firms tied to the rapidly evolving AI tools market. Early afternoon trading saw the stock at $13.80.

The newest pressure point is “agentic” software—AI that can operate across files and apps, not just respond to prompts. Anthropic is previewing a product called Cowork, targeting non-coders. Axios reported it’s currently limited to Claude Max users on macOS. Axios

William Blair analyst Arjun Bhatia weighed in Thursday, calling the market’s reaction to public software stocks “overstated.” He said the launch of Claude Cowork introduces another sentiment drag but isn’t a fundamental threat. Cowork, a premium upgrade linked to Anthropic’s Claude Max plan, starts at $100 per user per month, according to the report. Investors

C3.ai shares climbed 2.58% on Wednesday, closing at $13.91 and outpacing the broader market’s weaker performance. Still, the stock sits over 60% below its 52-week peak of $35.98, reached on Feb. 10.

The rebound came after a steep 4.17% fall on Tuesday, with shares closing at $13.56, ending a three-day run of gains.

The bigger question now is whether frontier model creators like Anthropic and OpenAI end up as partners or rivals to enterprise software vendors. RBC Capital Markets analysts, in a research note highlighted by Business Insider, pointed out that Anthropic’s recent product launches lined up with a selloff in stocks like Salesforce, Workday, and Snowflake. They cautioned that “the velocity of innovation and announcements from the model providers could continue to weigh” on the software sector through 2026. Business Insider

C3.ai, a provider of enterprise AI application software, posted $75.1 million in total revenue in its latest quarter. The company also reported holding $675.0 million in cash, cash equivalents, and marketable securities. CEO Stephen Ehikian highlighted that the quarter’s momentum came mainly from its federal business, noting, “The Federal market continues to be a large growth vector for us.” C3 AI

The downside risk remains for the stock. Should customers favor the major model providers more aggressively for workflow automation, smaller vendors could be squeezed by tougher pricing, extended sales cycles, and increased costs just to stay competitive — all factors that can quickly impact high-volatility stocks.

C3.ai is set to release its next earnings report around Feb. 25, per Zacks. Investors will focus on bookings and any changes to the company’s guidance on losses and growth during that update.

Stock Market Today

  • Options Traders Anticipate Significant Move in Amalgamated Financial Stock
    May 21, 2026, 10:19 AM EDT. Options market activity in Amalgamated Financial Corp. (AMAL) highlights elevated implied volatility on the May 16, 2025 $22.50 call option, signaling expectations of a major stock price movement. Implied volatility reflects anticipated market fluctuation; high levels suggest investor anticipation of a strong rally or sell-off. Despite this, Amalgamated Financial holds a modest Zacks Rank #3 (Hold) status with a neutral earnings forecast slightly lowered from 91 to 90 cents per share. Analysts have not upgraded estimates recently, dampening fundamental outlook. Some options traders may leverage high implied volatility to sell premium, speculating the stock's movement will be less extreme than forecast. The divergence between options market speculation and analyst outlook invites close attention to AMAL shares in coming months.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Previous Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop